Canadian cannabis licensed producer (LP) Aphria (TSX:APHA,NYSE:APHA) has officially rejected Green Growth Brands‘ (CSE:GGB) hostile takeover bid, the LP said in a statement on Wednesday (February 6).

In the announcement, Aphria said its board of directors agrees the hostile bid proposition “significantly undervalues” the company and would have negative effects, including being delisted from the Toronto Stock Exchange (TSX) and New York Stock Exchange (NYSE).

Green Growth filed its formal offer to acquire Aphria and all of its issued and outstanding shares on January 23. The deal would have given Aphria shareholders 1.5714 common shares of Green Growth for each Aphria share.

The takeover bid by Green Growth was first revealed at the end of last year, with the US operator giving a valuation of Aphria at approximately C$2.8 billion.

“The Aphria Board of Directors unanimously believes that [Green Growth Brand’s] hostile offer is significantly undervalued and inadequate and not in the interest of Aphria shareholders on multiple grounds,” Irwin D. Simon, independent board chair of Aphria, said in Wednesday’s release.

The LP’s board members said the hostile takeover reflects a 23-percent discount to its average share price, which is based on Green Growth and Aphria’s 20-day volume-weighted average prices before Green Growth’s initial proposal on December 27.

Aphria also said the hostile takeover would result in its shareholders giving Green Growth a 36-percent interest in the LP “in exchange for shares in a company with limited operations or other experience in the cannabis industry.”

The LP also claims that Green Growth has “no material synergies” and that Green Growth’s US retail concept “would contribute little to Aphria’s established Canadian and international medical and adult-use cannabis operations.”

In Green Growth’s formal takeover bid, the company said the “combination of the two companies is extremely compelling,” with the offer representing an “unparalleled enhancing opportunity and is a superior alternative to the status quo at Aphria.”

US Election 2020 and Cannabis

Investing in cannabis? Read what experts have to say about cannabis and the US Election!

“Green Growth invites Aphria shareholders to join Green Growth Brands in an exciting value-enhancing opportunity to create the only large-scale cannabis company to bridge US and Canadian markets,” Green Growth said in its January release.

However, Aphria claims it is committed to carrying out its own plans and intends to continue growing and providing value to its shareholders. Simon said:

“By virtue of our strong platform and competitive advantages, Aphria has multiple near-term opportunities to profitably grow and create substantial value for its shareholders. These include expanding production and automation to secure long-term cost and scale advantages, expanding in the global medical-use market in Europe, Latin America and the Caribbean, acquisition of increased market share in the Canadian adult-use markets, and developing new products for the burgeoning cannabis health and wellness sector. A hostile takeover by GGB ignores this bright outlook, which is another reason why the Aphria Board strongly urges shareholders to reject the bid.”

As of the time of this writing, Green Growth Brands had not released an official statement regarding Aphria’s rejection on its website, and declined a request for comment from the Investing News Network.

Shares of Aphria on the TSX were down 9.03 percent following Wednesday’s announcement, closing the trading session at C$12.80. Meanwhile, Green Growth Brands saw a 7.16-percent dip in value to close at C$5.45.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Jocelyn Aspa, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Green Growth Brands is a client of the Investing News Network. This article is not paid-for content.

US Election 2020 and Cannabis

Investing in cannabis? Read what experts have to say about cannabis and the US Election!

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less